InvestorNewsBreaks – Titan Partners Group LLC Expands Equity Research Division with Three Senior Analyst Appointments
May 12, 2026 — Titan Partners, a division of American Capital Partners, has appointed Scott Buck, Kyle Bauser, Ph. D.
InvestorBrandNetwork (IBN)
The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)InvestorNewsBreaks – AI Maverick Intel Inc. (OTC: AIMV) Issues Initial Consideration Shares for Proposed HEAL Access Canada Acquisition
May 12, 2026 — AI Maverick Intel (OTC: AIMV) announced the issuance of 76. 5 million common shares to HEAL Group Holdings as the initial tranche of consideration under the companies’ Right of First Refusal Agreement dated Feb.
RockBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Commences 2026 Drilling at Murdock Mountain Project
May 12, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.
InvestorNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Reports Broad Gold Intercepts at Swanson Project
May 12, 2026 — This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) reported results from its ongoing drilling program at the Swanson Gold Project, highlighting broad and continuous gold mineralization that supports expansion potential beyond the current mineral resource model and planned open-pit limits.
CryptoNewsBreaks – Bullish (NYSE: BLSH) to Acquire Equiniti in $4.2 Billion Transaction
May 12, 2026 — Bullish (NYSE: BLSH) has entered into a definitive agreement to acquire Equiniti, the parent company of Notified and a global transfer agent and shareholder services provider, in a transaction valued at $4. 2 billion.
InvestorNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) CEO Featured on TechMediaWire Podcast Discussing AI Voice Detection Platform
May 12, 2026 — This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.
Stock Performance Shows Investors Are Flocking to AI Bottlenecks
May 12, 2026 — An analysis of the semiconductor stocks performing exceptionally well reveals that all these companies provide a product that is regarded as a bottleneck in the AI boom. Several companies help to illustrate this insight.
Crypto Exchanges Ask Lawmakers to Delete Risky Tokens Language from Clarity Act
May 12, 2026 — Major crypto exchanges are reportedly stepping up efforts to influence legislation in Washington, seeking changes to a proposed market-structure measure that could significantly affect how digital assets are traded in the U. S.
AI Boom Triggers Rally in Cloud, Chip, and Cable Stocks
May 12, 2026 — Growing demand for artificial intelligence sparked gains across three corners of the technology sector on Thursday, May 8, highlighting how investment tied to AI is expanding beyond graphics processors and into the wider digital infrastructure ecosystem. Beyond those firms that have dominated global headlines regarding AI, others like GlobalTech Corp.
German Automaker Porsche to Lay Off 500 Workers
May 12, 2026 — German automaker Porsche has announced plans to cut more than 500 jobs as the company faces growing financial pressure and slowing demand for electric vehicles. The move is part of a wider restructuring effort aimed at helping the luxury carmaker focus on its main business operations during a difficult period for the global auto industry.
Why Peace Prospects Are Fueling Gold Rallies in 2026
May 12, 2026 — Gold’s behavior in 2026 has surprised many investors. Traditionally, geopolitical conflict in the Middle East sends investors rushing into safe-haven assets, pushing gold prices higher.
NHS Starts Offering Immunotherapy Injection to Cancer Patients
May 12, 2026 — The NHS in England is rolling out a treatment upgrade under which thousands of patients with cancer will now receive a one-minute injection of the immunotherapy pembrolizumab instead of having the drug administered via infusion as has been the case in the past. The jab slashes the administration time from hours to just a minute or two.
How Legacy Car Firms are Slowing the EV Transition
May 12, 2026 — A new survey of German car industry managers suggests the sector is further into its electric vehicle transition than public debate tends to imply, with a small group of slower-moving firms distorting the wider picture and potentially dragging down the broader shift. The research was carried out jointly by the University of Sussex and the Fraunhofer Institute for Systems and Innovation Research, drawing on responses from 74 industry managers gathered toward the end of 2025.
InvestorNewsBreaks – Lunai Bioworks, Inc. (NASDAQ: LNAI) Targets Alleged Naked Short Sellers in Securities Fraud Lawsuit
May 12, 2026 — Lunai Bioworks (NASDAQ: LNAI) is the plaintiff in a federal securities fraud lawsuit filed in Delaware by national law firms Dickinson Wright and Fox Rothschild, alleging that unidentified “naked” short sellers engaged in a coordinated scheme to manipulate trading in the company’s common stock. The complaint alleges repeated violations of SEC Regulation SHO, including failures to deliver shares reaching as high as 234.
BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
May 12, 2026 — This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q1 2026 Results, Highlights TONMYA Commercial Growth and Pipeline Progress
May 12, 2026 — Tonix Pharmaceuticals (NASDAQ: TNXP) reported first-quarter 2026 financial results while highlighting continued commercial momentum for TONMYA, its recently launched fibromyalgia treatment, and advancement across its clinical pipeline. The company said TONMYA, the first new fibromyalgia medicine in 15 years, has shown growth in prescriptions, prescribers, refills and patient access since its November 2025 launch, with a recently announced managed care agreement expanding potential coverage to approximately 35 million U.
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Report First Quarter 2026 Financial Results May 15
May 12, 2026 — Lantern Pharma (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company, announced that it will report its first-quarter 2026 operating and financial results via press release on May 15. The update will include financial results for the quarter ended March 31, 2026, along with operational updates regarding the company’s clinical trials and development of its proprietary artificial intelligence and machine learning platforms.
BioMedNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on AI-Powered Intoxication Detection
May 12, 2026 — This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.
BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on CNS Drug Delivery Innovation
May 12, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) announced its placement in a BioMedWire editorial examining emerging breakthroughs in central nervous system drug delivery and the growing market opportunities tied to overcoming the blood-brain barrier. The editorial highlights Oncotelic’s proprietary intranasal nose-to-brain delivery platform, which is designed to enable rapid, targeted therapeutic access to the brain, positioning the company within a broader industry effort to advance next-generation treatments for neurological disease, biodefense applications and other CNS-related conditions.
AINewsBreaks – Qdrant Powers Sapu AI Platform Indexing 28 Million PubMed Abstracts to Accelerate Cancer Research
May 12, 2026 — In a blog post by Daniel Azoulai, Qdrant highlighted how Sapu, an early-stage biopharmaceutical company developing treatments for hard-to-treat cancers, uses Qdrant Cloud infrastructure to power an AI research platform capable of indexing and querying all 28 million PubMed abstracts in a single searchable collection, helping accelerate biomedical discovery workflows. According to the post, Sapu’s AI platform evolved from an early prototype into a production-scale system supporting scientific literature review, standard operating procedure retrieval and AI-assisted research authorship.